Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

AEterna reports promising safety profile for Neovastat

July 31, 1997

Potential antitumor agents evaluated by Taiwan researchers

July 31, 1997

Daiichi's new anticancer agent enters overseas clinical trials

July 30, 1997

Inhibitors of cyclin-dependent protein kinases disclosed by CNRS researchers

July 30, 1997

Repligen identifies angiogenic growth factor inhibitors

July 29, 1997

Targeted Genetics cancer gene therapy product approved for European clinical trials

July 28, 1997

Allos Therapeutics reports clinical results of RSR13

July 28, 1997

Known heart failure drug studied for AML

July 28, 1997

Sparta's oral chemotherapeutic agent enters clinical trials

July 25, 1997

Cambridge NeuroScience awarded SBIR grant for cancer research

July 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...